情绪问题和自杀行为中多种药物使用问题的根源:一项横断面研究。

IF 2.8 3区 医学 Q3 NEUROSCIENCES
Tania E Martinez, Alejandro De la Torre-Luque, Anna Pedrola-Pons, Elizabeth Suarez-Soto
{"title":"情绪问题和自杀行为中多种药物使用问题的根源:一项横断面研究。","authors":"Tania E Martinez, Alejandro De la Torre-Luque, Anna Pedrola-Pons, Elizabeth Suarez-Soto","doi":"10.3390/brainsci15090940","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background/Objectives</b>: Problematic polydrug use represents a relevant public health concern, with strong relationships with mental health problems and suicide behavior. Existing studies have just focused on problematic use, overlooking the potentially cumulative effect of coexisting substance use and addictive behaviors. This study aims to analyze the association between the polydrug use profile (no problematic use, problematic use of a single drug, and polydrug use) and mental health outcomes, specifically anxiety symptoms, depressive symptoms, and suicide behavior. <b>Methods</b>: A sample of 1307 Spanish young adults (66.2% male; <i>M</i> = 21.2 years, <i>SD</i> = 3.31) were assessed for problematic use of substances and behavioral addictions as well as for the internalizing symptoms and suicide behavior. Participants were categorized into three groups: no problematic drug use (<i>n</i> = 880), problematic single drug use (<i>n</i> = 316), and polydrug use (<i>n</i> = 111). <b>Results</b>: Results showed an increasing level in depressive symptoms and suicide behavior with polydrug use, with significant differences between groups (<i>p</i> < 0.05). Moreover, both groups of problematic use presented higher levels of anxiety than no-use participants, regardless of the number of use modalities. <b>Conclusions</b>: These findings suggest that problematic polydrug use is associated with greater clinical severity, particularly in terms of depressive symptoms and suicide behavior, while anxiety remains elevated even when a problematic single drug pattern is observed. This study highlights the importance of considering polydrug use in dual diagnosis and the need for an integrative clinical approach.</p>","PeriodicalId":9095,"journal":{"name":"Brain Sciences","volume":"15 9","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12468127/pdf/","citationCount":"0","resultStr":"{\"title\":\"The Roots of Problematic Polydrug Use in Emotional Problems and Suicide Behavior: A Cross-Sectional Study.\",\"authors\":\"Tania E Martinez, Alejandro De la Torre-Luque, Anna Pedrola-Pons, Elizabeth Suarez-Soto\",\"doi\":\"10.3390/brainsci15090940\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background/Objectives</b>: Problematic polydrug use represents a relevant public health concern, with strong relationships with mental health problems and suicide behavior. Existing studies have just focused on problematic use, overlooking the potentially cumulative effect of coexisting substance use and addictive behaviors. This study aims to analyze the association between the polydrug use profile (no problematic use, problematic use of a single drug, and polydrug use) and mental health outcomes, specifically anxiety symptoms, depressive symptoms, and suicide behavior. <b>Methods</b>: A sample of 1307 Spanish young adults (66.2% male; <i>M</i> = 21.2 years, <i>SD</i> = 3.31) were assessed for problematic use of substances and behavioral addictions as well as for the internalizing symptoms and suicide behavior. Participants were categorized into three groups: no problematic drug use (<i>n</i> = 880), problematic single drug use (<i>n</i> = 316), and polydrug use (<i>n</i> = 111). <b>Results</b>: Results showed an increasing level in depressive symptoms and suicide behavior with polydrug use, with significant differences between groups (<i>p</i> < 0.05). Moreover, both groups of problematic use presented higher levels of anxiety than no-use participants, regardless of the number of use modalities. <b>Conclusions</b>: These findings suggest that problematic polydrug use is associated with greater clinical severity, particularly in terms of depressive symptoms and suicide behavior, while anxiety remains elevated even when a problematic single drug pattern is observed. This study highlights the importance of considering polydrug use in dual diagnosis and the need for an integrative clinical approach.</p>\",\"PeriodicalId\":9095,\"journal\":{\"name\":\"Brain Sciences\",\"volume\":\"15 9\",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-08-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12468127/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brain Sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/brainsci15090940\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"NEUROSCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/brainsci15090940","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

摘要

背景/目的:有问题的多种药物使用是一个相关的公共卫生问题,与精神健康问题和自杀行为密切相关。现有的研究只关注有问题的使用,忽视了共存的物质使用和成瘾行为的潜在累积效应。本研究旨在分析多种药物使用情况(无问题使用、有问题使用单一药物和多种药物使用)与心理健康结果,特别是焦虑症状、抑郁症状和自杀行为之间的关系。方法:对1307名西班牙年轻人(66.2%为男性,M = 21.2岁,SD = 3.31)进行药物使用问题、行为成瘾、内化症状和自杀行为的评估。参与者分为三组:无问题药物使用(n = 880),有问题的单一药物使用(n = 316)和多种药物使用(n = 111)。结果:多药使用组抑郁症状和自杀行为水平升高,组间差异有统计学意义(p < 0.05)。此外,无论使用方式的多少,两组有问题的使用都比没有使用的参与者表现出更高的焦虑水平。结论:这些发现表明,有问题的多种药物使用与更严重的临床严重程度有关,特别是在抑郁症状和自杀行为方面,而即使观察到有问题的单一药物模式,焦虑仍会升高。这项研究强调了在双重诊断中考虑多种药物使用的重要性和综合临床方法的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Roots of Problematic Polydrug Use in Emotional Problems and Suicide Behavior: A Cross-Sectional Study.

Background/Objectives: Problematic polydrug use represents a relevant public health concern, with strong relationships with mental health problems and suicide behavior. Existing studies have just focused on problematic use, overlooking the potentially cumulative effect of coexisting substance use and addictive behaviors. This study aims to analyze the association between the polydrug use profile (no problematic use, problematic use of a single drug, and polydrug use) and mental health outcomes, specifically anxiety symptoms, depressive symptoms, and suicide behavior. Methods: A sample of 1307 Spanish young adults (66.2% male; M = 21.2 years, SD = 3.31) were assessed for problematic use of substances and behavioral addictions as well as for the internalizing symptoms and suicide behavior. Participants were categorized into three groups: no problematic drug use (n = 880), problematic single drug use (n = 316), and polydrug use (n = 111). Results: Results showed an increasing level in depressive symptoms and suicide behavior with polydrug use, with significant differences between groups (p < 0.05). Moreover, both groups of problematic use presented higher levels of anxiety than no-use participants, regardless of the number of use modalities. Conclusions: These findings suggest that problematic polydrug use is associated with greater clinical severity, particularly in terms of depressive symptoms and suicide behavior, while anxiety remains elevated even when a problematic single drug pattern is observed. This study highlights the importance of considering polydrug use in dual diagnosis and the need for an integrative clinical approach.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Brain Sciences
Brain Sciences Neuroscience-General Neuroscience
CiteScore
4.80
自引率
9.10%
发文量
1472
审稿时长
18.71 days
期刊介绍: Brain Sciences (ISSN 2076-3425) is a peer-reviewed scientific journal that publishes original articles, critical reviews, research notes and short communications in the areas of cognitive neuroscience, developmental neuroscience, molecular and cellular neuroscience, neural engineering, neuroimaging, neurolinguistics, neuropathy, systems neuroscience, and theoretical and computational neuroscience. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. Electronic files or software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信